NRF2 signalling in environmental metal and metalloid neurotoxicity: distinguishing stress responses from functional neuroprotection
4 affiliations
- 1Human Anatomy Unit, Department of Medicine and Clinical Sciences, School of Medicine, Eden University, Lusaka, Zambia
- 2Department of Human Anatomy, School of Medicine and Health Science, Mulungushi University, Livingstone, Zambia
- 3Department of Medicine and Clinical Sciences, School of Medicine, Eden University, Lusaka, Zambia
- 4Department of Human Anatomy, University of Cross River State, Calabar, Nigeria
Abstract
Exposure to toxic metals and metalloids is an important public health concern because they can damage the nervous system and impair cognitive and motor function. Oxidative stress, disturbed glutathione balance, mitochondrial dysfunction and neuroinflammation are common features of this damage. Nuclear factor erythroid 2-related factor 2 (NRF2) regulates proteins that help cells maintain redox balance and withstand toxic stress. Increased NRF2 expression after metal exposure is therefore often interpreted as evidence of protection. However, expression alone does not show that the pathway is working effectively. Functional activation requires NRF2 nuclear translocation, binding to antioxidant-response elements, induction of target genes and improvement in redox or mitochondrial function. This review critically examines human, animal and cellular evidence concerning NRF2 responses to cadmium, lead, mercury, arsenic and manganese. It considers how dose, duration, brain region and cell type shape these responses and evaluates compounds intended to modify NRF2 signalling. It assesses whether NRF2 dependence was demonstrated using genetic deletion, knockdown, pharmacological inhibition or rescue rather than inferred from expression changes. Current evidence supports NRF2 as an important but context-dependent defence mechanism. However, causal evidence remains uneven, human data are limited and many proposed activators have effects beyond NRF2. Future studies should use environmentally relevant exposures and directly measure pathway activity, mitochondrial function and neurological outcomes. This is necessary to determine whether NRF2 modulation can provide safe and meaningful protection against environmental neurotoxicity.
Related
- Extracellular Vesicles Derived from L-MYC Neural Stem Cells Mediate Neuroprotection in 3D Models of Chemotherapy- and Radiation-Induced Neurotoxicity
- Paradoxical relief after seizures: a diagnostic signal distinguishing functional/dissociative from epileptic seizures
- Psychometric properties and longitudinal measurement invariance of the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale in the Chinese colorectal cancer chemotherapy population.
- Chemotherapy and neuroprotection: one carbazole compound, two functions
- Zileuton Beyond Asthma: A Multifaceted 5-Lipoxygenase Inhibitor With Emerging Therapeutic Potential Across Inflammation, Cancer, Neuroprotection, and Fibrosis
BibTeX
@article{mesole2026nrf2,
title = {{NRF2 signalling in environmental metal and metalloid neurotoxicity: distinguishing stress responses from functional neuroprotection}},
author = {Bolaji Samuel Mesole and Uthman Ademola Yusuf and Alfred Omachonu Okpanachi and Rademene Sunday Oria and Flavien Nsoni Bumbangi},
journal = {Frontiers in Toxicology},
year = {2026},
month = oct,
doi = {10.3389/ftox.2026.1988769},
url = {https://doi.org/10.3389/ftox.2026.1988769},
note = {CC BY},
}
RIS
TY - JOUR
TI - NRF2 signalling in environmental metal and metalloid neurotoxicity: distinguishing stress responses from functional neuroprotection
AU - Bolaji Samuel Mesole
AU - Uthman Ademola Yusuf
AU - Alfred Omachonu Okpanachi
AU - Rademene Sunday Oria
AU - Flavien Nsoni Bumbangi
PY - 2026
DA - 2026/10/26
JO - Frontiers in Toxicology
DO - 10.3389/ftox.2026.1988769
UR - https://doi.org/10.3389/ftox.2026.1988769
AB - Exposure to toxic metals and metalloids is an important public health concern because they can damage the nervous system and impair cognitive and motor function. Oxidative stress, disturbed glutathione balance, mitochondrial dysfunction and neuroinflammation are common features of this damage. Nuclear factor erythroid 2-related factor 2 (NRF2) regulates proteins that help cells maintain redox balance and withstand toxic stress. Increased NRF2 expression after metal exposure is therefore often interpreted as evidence of protection. However, expression alone does not show that the pathway is working effectively. Functional activation requires NRF2 nuclear translocation, binding to antioxidant-response elements, induction of target genes and improvement in redox or mitochondrial function. This review critically examines human, animal and cellular evidence concerning NRF2 responses to cadmium, lead, mercury, arsenic and manganese. It considers how dose, duration, brain region and cell type shape these responses and evaluates compounds intended to modify NRF2 signalling. It assesses whether NRF2 dependence was demonstrated using genetic deletion, knockdown, pharmacological inhibition or rescue rather than inferred from expression changes. Current evidence supports NRF2 as an important but context-dependent defence mechanism. However, causal evidence remains uneven, human data are limited and many proposed activators have effects beyond NRF2. Future studies should use environmentally relevant exposures and directly measure pathway activity, mitochondrial function and neurological outcomes. This is necessary to determine whether NRF2 modulation can provide safe and meaningful protection against environmental neurotoxicity.
SN - 2673-3080
ER -